{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:41:02Z","timestamp":1791207662119,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.molmed.2012.09.008","type":"journal-article","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T20:39:45Z","timestamp":1350506385000},"page":"679-688","source":"Crossref","is-referenced-by-count":183,"title":["Sense from nonsense: therapies for premature stop codon diseases"],"prefix":"10.1016","volume":"18","author":[{"given":"Laure","family":"Bidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Allamand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Rousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Namy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2012.09.008_bib0005","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.gt.3302211","article-title":"Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment","volume":"11","author":"Bidou","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.molmed.2012.09.008_bib0010","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1531-8249(200008)48:2<164::AID-ANA5>3.0.CO;2-B","article-title":"Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy","volume":"48","author":"Howard","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0015","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1017\/S1355838200000716","article-title":"Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system","volume":"6","author":"Manuvakhova","year":"2000","journal-title":"RNA"},{"key":"10.1016\/j.molmed.2012.09.008_bib0020","doi-asserted-by":"crossref","first-page":"e1002608","DOI":"10.1371\/journal.pgen.1002608","article-title":"Statistical analysis of readthrough levels for nonsense mutations in mammalian cells reveals a major determinant of response to gentamicin","volume":"8","author":"Floquet","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.molmed.2012.09.008_bib0025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI7866","article-title":"Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice","volume":"104","author":"Barton-Davis","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2012.09.008_bib0030","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tig.2008.08.010","article-title":"Introducing sense into nonsense in treatments of human genetic diseases","volume":"24","author":"Linde","year":"2008","journal-title":"Trends Genet."},{"key":"10.1016\/j.molmed.2012.09.008_bib0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.clpt.6100012","article-title":"Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy","volume":"81","author":"Zingman","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.molmed.2012.09.008_bib0040","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1164\/ajrccm.163.7.2004001","article-title":"Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis","volume":"163","author":"Clancy","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.molmed.2012.09.008_bib0045","first-page":"15","article-title":"Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results","volume":"22","author":"Politano","year":"2003","journal-title":"Acta Myol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0050","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ana.1023","article-title":"Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations","volume":"49","author":"Wagner","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0055","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1164\/ajrccm.161.3.9904116","article-title":"A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations","volume":"161","author":"Wilschanski","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.molmed.2012.09.008_bib0060","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.22024","article-title":"Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy","volume":"67","author":"Malik","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1741-7015-5-5","article-title":"In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study","volume":"5","author":"Sermet-Gaudelus","year":"2007","journal-title":"BMC Med."},{"key":"10.1016\/j.molmed.2012.09.008_bib0070","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/humu.20763","article-title":"A meta-analysis of nonsense mutations causing human genetic disease","volume":"29","author":"Mort","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molmed.2012.09.008_bib0075","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1074\/jbc.M806728200","article-title":"Poly-L-aspartic acid enhances and prolongs gentamicin-mediated suppression of the CFTR-G542X mutation in a cystic fibrosis mouse model","volume":"284","author":"Du","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2012.09.008_bib0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ja.2005.45","article-title":"Prevention of neomycin-induced nephrotoxic event in pig proximal tubular epithelial cell line by apolipoprotein E3","volume":"58","author":"Takamoto","year":"2005","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.molmed.2012.09.008_bib0085","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.bmc.2010.03.060","article-title":"Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations","volume":"18","author":"Nudelman","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.molmed.2012.09.008_bib0090","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1097-2765(04)00206-0","article-title":"Crystal structure and functional analysis of the eukaryotic class II release factor eRF3 from S. pombe","volume":"14","author":"Kong","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2012.09.008_bib0095","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1111\/j.1742-4658.2010.07672.x","article-title":"NMR solution structure and function of the C-terminal domain of eukaryotic class 1 polypeptide chain release factor","volume":"277","author":"Mantsyzov","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.molmed.2012.09.008_bib0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0092-8674(00)80667-4","article-title":"The crystal structure of human eukaryotic release factor eRF1\u2013mechanism of stop codon recognition and peptidyl-tRNA hydrolysis","volume":"100","author":"Song","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2012.09.008_bib0105","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1093\/nar\/gkq338","article-title":"Decoding accuracy in eRF1 mutants and its correlation with pleiotropic quantitative traits in yeast","volume":"38","author":"Merritt","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2012.09.008_bib0110","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/nar\/gkp012","article-title":"Molecular dissection of translation termination mechanism identifies two new critical regions in eRF1","volume":"37","author":"Hatin","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2012.09.008_bib0115","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1017\/S1355838200000777","article-title":"Terminating eukaryote translation: domain 1 of release factor eRF1 functions in stop codon recognition","volume":"6","author":"Bertram","year":"2000","journal-title":"RNA"},{"key":"10.1016\/j.molmed.2012.09.008_bib0120","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.molcel.2008.03.020","article-title":"Distinct eRF3 requirements suggest alternate eRF1 conformations mediate peptide release during eukaryotic translation termination","volume":"30","author":"Fan-Minogue","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2012.09.008_bib0125","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1111\/j.1742-4658.2007.05949.x","article-title":"Eukaryotic class 1 translation termination factor eRF1--the NMR structure and dynamics of the middle domain involved in triggering ribosome-dependent peptidyl-tRNA hydrolysis","volume":"274","author":"Ivanova","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.molmed.2012.09.008_bib0130","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2958.2003.03301.x","article-title":"The essential role of the invariant GGQ motif in the function and stability in vivo of bacterial release factors RF1 and RF2","volume":"47","author":"Mora","year":"2003","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0135","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1093\/nar\/29.19.3982","article-title":"Class-1 translation termination factors: invariant GGQ minidomain is essential for release activity and ribosome binding but not for stop codon recognition","volume":"29","author":"Seit-Nebi","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2012.09.008_bib0140","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1365-2958.1999.01346.x","article-title":"The C-terminus of eRF1 defines a functionally important domain for translation termination in Saccharomyces cerevisiae","volume":"32","author":"Eurwilaichitr","year":"1999","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0145","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.cell.2006.04.035","article-title":"In vitro reconstitution of eukaryotic translation reveals cooperativity between release factors eRF1 and eRF3","volume":"125","author":"Alkalaeva","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2012.09.008_bib0150","doi-asserted-by":"crossref","first-page":"40224","DOI":"10.1074\/jbc.M607461200","article-title":"Kinetic analysis of interaction of eukaryotic release factor 3 with guanine nucleotides","volume":"281","author":"Pisareva","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2012.09.008_bib0155","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1128\/MCB.24.17.7769-7778.2004","article-title":"GTP hydrolysis by eRF3 facilitates stop codon decoding during eukaryotic translation termination","volume":"24","author":"Salas-Marco","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0160","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1101\/gad.1770109","article-title":"Structural insights into eRF3 and stop codon recognition by eRF1","volume":"23","author":"Cheng","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2012.09.008_bib0165","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1126\/science.1212642","article-title":"The structure of the eukaryotic ribosome at 3.0 A resolution","volume":"334","author":"Ben-Shem","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.molmed.2012.09.008_bib0170","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cell.2005.09.039","article-title":"Crystal structures of the ribosome in complex with release factors RF1 and RF2 bound to a cognate stop codon","volume":"123","author":"Petry","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2012.09.008_bib0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature01224","article-title":"A cryo-electron microscopic study of ribosome-bound termination factor RF2","volume":"421","author":"Rawat","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2012.09.008_bib0180","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.molcel.2007.06.032","article-title":"A model for how ribosomal release factors induce peptidyl-tRNA cleavage in termination of protein synthesis","volume":"27","author":"Trobro","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2012.09.008_bib0185","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/35003097","article-title":"A tripeptide \u2018anticodon\u2019 deciphers stop codons in messenger RNA","volume":"403","author":"Ito","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2012.09.008_bib0190","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1097-2765(02)00691-3","article-title":"Release of peptide promoted by the GGQ motif of class 1 release factors regulates the GTPase activity of RF3","volume":"10","author":"Zavialov","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2012.09.008_bib0195","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature07115","article-title":"Structural basis for translation termination on the 70S ribosome","volume":"454","author":"Laurberg","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2012.09.008_bib0200","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1126\/science.1164840","article-title":"Insights into translational termination from the structure of RF2 bound to the ribosome","volume":"322","author":"Weixlbaumer","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.molmed.2012.09.008_bib0205","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4615-4897-3_4","article-title":"Aminoglycoside antibiotics. Structures, functions, and resistance","volume":"456","author":"Wright","year":"1998","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0210","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1093\/nar\/gki862","article-title":"Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding","volume":"33","author":"Francois","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2012.09.008_bib0215","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0022-2836(90)90016-F","article-title":"Binding of tRNA to the ribosomal A and P sites protects two distinct sets of nucleotides in 16 S rRNA","volume":"211","author":"Moazed","year":"1990","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0220","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1126\/science.285.5434.1722","article-title":"Recognition of the codon-anticodon helix by ribosomal RNA","volume":"285","author":"Yoshizawa","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.molmed.2012.09.008_bib0225","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature10913","article-title":"A new understanding of the decoding principle on the ribosome","volume":"484","author":"Demeshkina","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2012.09.008_bib0230","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/cbic.200300657","article-title":"The molecular basis for A-site mutations conferring aminoglycoside resistance: relationship between ribosomal susceptibility and X-ray crystal structures","volume":"4","author":"Pfister","year":"2003","journal-title":"Chembiochem"},{"key":"10.1016\/j.molmed.2012.09.008_bib0235","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/nm1197-1280","article-title":"Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line","volume":"3","author":"Bedwell","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2012.09.008_bib0240","first-page":"27","article-title":"Aminoglycoside nephrotoxicity","volume":"17","author":"Swan","year":"1997","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000013861","article-title":"Aminoglycoside antibiotics","volume":"5","author":"Forge","year":"2000","journal-title":"Audiol. Neurootol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0250","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/0006-2952(95)02160-4","article-title":"Formation of free radicals by gentamicin and iron and evidence for an iron\/gentamicin complex","volume":"50","author":"Priuska","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0255","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/nar\/gkh201","article-title":"The major 5\u2032 determinant in stop codon read-through involves two adjacent adenines","volume":"32","author":"Tork","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2012.09.008_bib0260","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/embo-reports\/kve176","article-title":"Impact of the six nucleotides downstream of the stop codon on translation termination","volume":"2","author":"Namy","year":"2001","journal-title":"EMBO Rep."},{"key":"10.1016\/j.molmed.2012.09.008_bib0265","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7164\/antibiotics.23.170","article-title":"A new antibiotic, negamycin","volume":"23","author":"Hamada","year":"1970","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.molmed.2012.09.008_bib0270","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0005-2787(74)90201-9","article-title":"Negamycin inhibits termination of protein synthesis directed by phage f2 RNA in vitro","volume":"374","author":"Uehara","year":"1974","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2012.09.008_bib0275","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jb\/mvg203","article-title":"Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice","volume":"134","author":"Arakawa","year":"2003","journal-title":"J. Biochem."},{"key":"10.1016\/j.molmed.2012.09.008_bib0280","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1128\/AAC.00455-07","article-title":"Negamycin binds to the wall of the nascent chain exit tunnel of the 50S ribosomal subunit","volume":"51","author":"Schroeder","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molmed.2012.09.008_bib0285","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jgm.1140","article-title":"Drug-induced readthrough of premature stop codons leads to the stabilization of laminin \u03b12 chain mRNA in CMD myotubes","volume":"10","author":"Allamand","year":"2008","journal-title":"J. Gene Med."},{"key":"10.1016\/j.molmed.2012.09.008_bib0290","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00063030-200923030-00003","article-title":"Pharmaceuticals targeting nonsense mutations in genetic diseases: progress in development","volume":"23","author":"Rowe","year":"2009","journal-title":"BioDrugs"},{"key":"10.1016\/j.molmed.2012.09.008_bib0295","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2012.09.008_bib0300","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1073\/pnas.0909141107","article-title":"Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124","volume":"107","author":"Auld","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2012.09.008_bib0305","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1073\/pnas.0813345106","article-title":"Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression","volume":"106","author":"Auld","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2012.09.008_bib0310","doi-asserted-by":"crossref","first-page":"E64","DOI":"10.1073\/pnas.0901936106","article-title":"Nonsense suppression activity of PTC124 (ataluren)","volume":"106","author":"Peltz","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2012.09.008_bib0315","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1177\/0883073810371129","article-title":"Read-Through strategies for suppression of nonsense mutations in Duchenne\/Becker muscular dystrophy: aminoglycosides and ataluren (PTC124)","volume":"25","author":"Finkel","year":"2010","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0320","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/wrna.95","article-title":"Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases","volume":"2","author":"Keeling","year":"2011","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.molmed.2012.09.008_bib0325","doi-asserted-by":"crossref","first-page":"14658","DOI":"10.1073\/pnas.232580599","article-title":"Resistance to the macrolide antibiotic tylosin is conferred by single methylations at 23S rRNA nucleotides G748 and A2058 acting in synergy","volume":"99","author":"Liu","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2012.09.008_bib0330","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/gut.2008.169805","article-title":"Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons","volume":"59","author":"Zilberberg","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.molmed.2012.09.008_bib0335","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00018-009-0177-1","article-title":"Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors","volume":"67","author":"Nicholson","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.molmed.2012.09.008_bib0340","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ceb.2009.02.007","article-title":"Execution of nonsense-mediated mRNA decay: what defines a substrate?","volume":"21","author":"Rebbapragada","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0345","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ymthe.2006.04.011","article-title":"Specific inhibition of nonsense-mediated mRNA decay components, SMG-1 or Upf1, rescues the phenotype of Ullrich disease fibroblasts","volume":"14","author":"Usuki","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2012.09.008_bib0350","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1128\/MCB.26.4.1272-1287.2006","article-title":"hUPF2 silencing identifies physiologic substrates of mammalian nonsense-mediated mRNA decay","volume":"26","author":"Wittmann","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0355","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.exer.2008.05.016","article-title":"Systemic aminoglycoside treatment in rodent models of retinitis pigmentosa","volume":"87","author":"Guerin","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.molmed.2012.09.008_bib0360","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/jnr.22409","article-title":"Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro","volume":"88","author":"Popescu","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.molmed.2012.09.008_bib0365","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1152\/japplphysiol.01366.2009","article-title":"Membrane blebbing as an assessment of functional rescue of dysferlin-deficient human myotubes via nonsense suppression","volume":"109","author":"Wang","year":"2010","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0370","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00109-002-0363-1","article-title":"Aminoglycoside suppression of a premature stop mutation in a Cftr\u2013\/\u2013 mouse carrying a human CFTR-G542X transgene","volume":"80","author":"Du","year":"2002","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.molmed.2012.09.008_bib0375","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00109-006-0045-5","article-title":"Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model","volume":"84","author":"Du","year":"2006","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.molmed.2012.09.008_bib0380","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJMoa022170","article-title":"Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations","volume":"349","author":"Wilschanski","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2012.09.008_bib0385","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00109-001-0317-z","article-title":"Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system","volume":"80","author":"Keeling","year":"2002","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.molmed.2012.09.008_bib0390","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1093\/nar\/gkq1277","article-title":"Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides","volume":"39","author":"Floquet","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2012.09.008_bib0395","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/nar\/26.1.269","article-title":"APC gene: database of germline and somatic mutations in human tumors and cell lines","volume":"26","author":"Laurent-Puig","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2012.09.008_bib0400","doi-asserted-by":"crossref","first-page":"e24125","DOI":"10.1371\/journal.pone.0024125","article-title":"Readthrough of premature termination codons in the adenomatous polyposis coli gene restores its biological activity in human cancer cells","volume":"6","author":"Floquet","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2012.09.008_bib0405","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI28523","article-title":"Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin","volume":"117","author":"Linde","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2012.09.008_bib0410","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1083\/jcb.200611086","article-title":"Inhibition of nonsense-mediated mRNA decay (NMD) by a new chemical molecule reveals the dynamic of NMD factors in P-bodies","volume":"178","author":"Durand","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0415","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0076-6879(10)78021-6","article-title":"Aminoglycosides redesign strategies for improved antibiotics and compounds for treatment of human genetic diseases","volume":"478","author":"Pokrovskaya","year":"2010","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.molmed.2012.09.008_bib0420","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1084\/jem.20081940","article-title":"Nonaminoglycoside compounds induce readthrough of nonsense mutations","volume":"206","author":"Du","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2012.09.008_bib0425","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1093\/hmg\/dds223","article-title":"Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy","volume":"21","author":"Kayali","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2012.09.008_bib0430","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/cbic.200900779","article-title":"The future of aminoglycosides: the end or renaissance?","volume":"11","author":"Houghton","year":"2010","journal-title":"Chembiochem"},{"key":"10.1016\/j.molmed.2012.09.008_bib0435","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1021\/jm801640k","article-title":"Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations","volume":"52","author":"Nudelman","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molmed.2012.09.008_bib0440","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1039\/b801498a","article-title":"Efficient total synthesis of (+)-negamycin, a potential chemotherapeutic agent for genetic diseases","volume":"20","author":"Hayashi","year":"2008","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.molmed.2012.09.008_bib0445","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.1016\/0169-6009(89)90001-9","article-title":"In memory of Constantine Spiro Anast","volume":"5","author":"Crigler","year":"1989","journal-title":"Bone Miner."},{"key":"10.1016\/j.molmed.2012.09.008_bib0455","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00109-011-0787-6","article-title":"Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54","volume":"89","author":"Rowe","year":"2011","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.molmed.2012.09.008_bib0460","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2011.10.005","article-title":"The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse","volume":"105","author":"Wang","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.molmed.2012.09.008_bib0465","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1093\/hmg\/ddp333","article-title":"Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model","volume":"18","author":"Mattis","year":"2009","journal-title":"Hum. Mol. Genet."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491412001852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491412001852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T10:31:04Z","timestamp":1714473064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491412001852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":92,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1471491412001852"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2012.09.008","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}